Evidence map›Paper›PMID 40428138›Full record

ReviewBioengineering (Basel, Switzerland)2025

Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.

Abdullah Jabri, Bader Taftafa, Abdulaziz Mhannayeh, Mohamed Alsharif, Tasnim Abbad, Sana Ahmed, Eman A Alshehri, Abdulrahman Elsalti, Jibran Khan, Tanveer Ahmad Mir and 1 more

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abdullah JabriCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0009-0000-8048-9528
Bader TaftafaCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0009-0002-3146-9218
Abdulaziz MhannayehCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0009-0009-4809-7554
Mohamed AlsharifCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Tasnim AbbadCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Sana AhmedTissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence (TR&I-Dpt), King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Eman A AlshehriTissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence (TR&I-Dpt), King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Abdulrahman ElsaltiInternational School of Medicine, Istanbul Medipol University, Istanbul 34810, Turkey.ORCID 0000-0002-4130-3978
Jibran KhanCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Tanveer Ahmad MirCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0000-0002-0093-0924
Ahmed YaqinuddinCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0000-0001-7536-910X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases (CVD) are the primary cause of death and disability around the world. Over the past decades, several conventional model systems based on two-dimensional (3D) monolayer cultures or experimental animals have been adopted to dissect and understand heart diseases in order to develop treatment modalities. However, traditional models exhibit several limitations in recapitulating human-specific key physiological and pathological characteristics, which highlights the necessity of developing physiologically relevant models. In recent years, tissue engineering approaches have been extensively employed to generate revolutionary three-dimensional (3D) cardiac models. In particular, the combined use of various bioengineering strategies and cellular reprogramming approaches has facilitated the development of various models. This review presents an overview of different approaches (bioprinting, scaffolding, and electrospinning) for creating bioengineered cardiac tissue models. Next, a broad survey of recent research related to the modeling of various cardiac diseases is presented. Finally, current challenges and future directions are proposed to foster further developments in the field of cardiac tissue engineering.

Indexed as

bioengineeringcardiovascular systemdisease modelingin vitro modelsregenerative medicine

Identifiers

PMID40428138
PMCPMC12109445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.